| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-09 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |